Related references
Note: Only part of the references are listed.Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant
Yun Fan et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2019)
Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation
Christoph Schmid et al.
HAEMATOLOGICA (2018)
Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation
Christoph Schmid et al.
HAEMATOLOGICA (2018)
Outcome following second allogeneic hematopoietic cell transplantation: A single-center experience
Hassan A. Aljasem et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes
R. Vrhovac et al.
BONE MARROW TRANSPLANTATION (2016)
Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes
Christine N. Duncan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT
T. Ruutu et al.
BONE MARROW TRANSPLANTATION (2015)
Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients
Christelle Ferra et al.
LEUKEMIA & LYMPHOMA (2015)
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part III. Prevention and Treatment of Relapse after Allogeneic Transplantation
Marcos de Lima et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Outcome of Donor Lymphocyte Infusion after T Cell-depleted Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndromes
Pramila Krishnamurthy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Graft failure in the modern era of allogeneic hematopoietic SCT
R. Olsson et al.
BONE MARROW TRANSPLANTATION (2013)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Peripheral Blood as a Preferable Source of Stem Cells for Salvage Transplantation in Patients with Graft Failure after Cord Blood Transplantation: A Retrospective Analysis of the Registry Data of the Japanese Society for Hematopoietic Cell Transplantation
Shigeo Fuji et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid et al.
BLOOD (2012)
Feasibility of Reduced-Intensity Cord Blood Transplantation as Salvage Therapy for Graft Failure: Results of a Nationwide Survey of Adult Patients
Fusako Waki et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Prevention and treatment of acute myeloid leukemia relapse after allogeneic stem cell transplantation
Betul Oran et al.
CURRENT OPINION IN HEMATOLOGY (2011)
Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation
Claire Roddie et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Donor Lymphocyte Infusions Modulate Relapse Risk in Mixed Chimeras and Induce Durable Salvage in Relapsed Patients After T-Cell-Depleted Allogeneic Transplantation for Hodgkin's Lymphoma
Karl S. Peggs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
David L. Porter et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Second Unrelated Donor Hematopoietic Cell Transplantation for Primary Graft Failure
Jeffrey Schriber et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia
Philippe Guardiola et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Defining the Intensity of Conditioning Regimens: Working Definitions
Andrea Bacigalupo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Nicolaus Kroeger et al.
BLOOD (2009)
Graft failure after allogeneic hematopoietic cell transplantation
Jonas Mattsson et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation.: Results of a single institution analysis
Gabriela Rondon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation
D. A. Pollyea et al.
BONE MARROW TRANSPLANTATION (2007)
Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis
Nicolaus Kroeger et al.
BLOOD (2007)
Treatment of relapsed acute leukemia after allogeneic transplantation: A single center experience
Martha L. Arellano et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Mini-review - Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation
SN Wolff
BONE MARROW TRANSPLANTATION (2002)
Share Paper
